|
|
Volumn 25, Issue 7, 2011, Pages 599-605
|
|
Fragment-based drug discovery: What really works. An interview with Sandy Farmer of Boehringer Ingelheim
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOEHRINGER INGELHEIM;
DRUG DISCOVERY;
DRUG PRODUCTS;
CHEMISTRY;
COST;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SOLUBILITY;
DRUG STRUCTURE;
FRAGMENT BASED DRUG DISCOVERY;
HIGH THROUGHPUT SCREENING;
NOTE;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
QUALITY CONTROL;
SURFACE PLASMON RESONANCE;
|
|
EID: 80051794377
PISSN: 0920654X
EISSN: 15734951
Source Type: Journal
DOI: 10.1007/s10822-011-9457-6 Document Type: Note |
|
Times cited : (5)
|
|
References (1)
|
